Antibody replacement therapy in primary antibody deficiencies and iatrogenic hypogammaglobulinemia.

about

Antibody replacement therapy in primary antibody deficiencies and iatrogenic hypogammaglobulinemia.

Item

http://www.wikidata.org/entity/Q38548417

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antibody replacement therapy i ...... rogenic hypogammaglobulinemia.

@en

type

Item

label

Antibody replacement therapy i ...... rogenic hypogammaglobulinemia.

@en

prefLabel

Antibody replacement therapy i ...... rogenic hypogammaglobulinemia.

@en

P1476

Antibody replacement therapy i ...... rogenic hypogammaglobulinemia.

@en

P2093

Diana A van Kessel

http://www.w3.org/2001/XMLSchema#string

Ger T Rijkers

http://www.w3.org/2001/XMLSchema#string

Heleen van Velzen-Blad

http://www.w3.org/2001/XMLSchema#string

Jan C Grutters

http://www.w3.org/2001/XMLSchema#string

Thijs W Hoffman

http://www.w3.org/2001/XMLSchema#string

P2860

CD20 deficiency in humans results in impaired T cell-independent antibody responses

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Population prevalence of diagnosed primary immunodeficiency diseases in the United States

Practice parameter for the diagnosis and management of primary immunodeficiency

Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data.

Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy.

Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab

Does rituximab aggravate pre-existing hypogammaglobulinaemia?

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.

P304

921-933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2015.1049599

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26181342

http://www.w3.org/2001/XMLSchema#string